Search results with tag "Nivolumab"
DRUG NAME: Nivolumab - BC Cancer
www.bccancer.bc.caNivolumab • avoid systemic . corticosteroids. or . immunosuppressants. prior to starting nivolumab due to potential interference with the efficacy of nivolumab; corticosteroids or immunosuppressants may be used during treatment with
Opdivo® (nivolumab) Injectable Medication …
www.aetna.comWill Opdivo (nivolumab) be used as a single agent? Please select the clinical setting in which Opdivo (nivolumab) will be used: Unresectable disease . Recurrent disease . Metastatic disease . Other . What is the place in therapy in which the requested drug will be used? First-line treatment . Subsequent treatment . Extranodal NK/T-cell lymphoma ...
AUSTRALIAN PRODUCT INFORMATION OPDIVO …
www.medicines.org.auau_pi_opdivo_v14.0 1 australian product information opdivo® (nivolumab) warning: immune-related adverse reactions with opdivo and yervoy (ipilimumab) combination therapy
ALLEGATO I RIASSUNTO DELLE CARATTERISTICHE …
www.ema.europa.eu4 OPDIVO in associazione ad ipilimumab Melanoma La dose raccomandata è 1 mg/kg di nivolumab in associazione a 3 mg/kg di ipilimumab somministrato
HIGHLIGHTS OF PRESCRIBING INFORMATION • Recurrent or ...
packageinserts.bms.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Unresectable or Metastatic Melanoma OPDIVO® (nivolumab), as a single agent or in combination with ipilimumab, is indicated for the treatment of patients with unresectable or metastatic melanoma.